Keiserman相关文献与解析，生知库 | 链接生命科学的每一步

Fernandez-Moreno, Josefina-Patricia; Fenech, Mario; Yaschenko, Anna E; Zhao, Chengsong; Neubauer, Matthew; Davis, Hannah N; Marchi, Alex J; Concannon, Raine; Keren-Keiserman, Alexandra; Reuveni, Moshe; Levitsky, Victor; Oshchepkov, Dmitry; Dolgikh, Vladislav; Goldshmidt, Alexander; Ascencio-Ibáñez, José T; Zemlyanskaya, Elena; Alonso, Jose M; Stepanova, Anna N

发表日期：2026

文献求助收藏

Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-Week Results from the KEEPsAKE 1 and KEEPsAKE 2 Randomized Clinical Trials

Risankizumab治疗活动性银屑病关节炎的疗效和安全性：KEEPsAKE 1和KEEPsAKE 2随机临床试验的196周结果

期刊:Rheumatology and Therapy

影响因子:2.9

doi:10.1007/s40744-025-00793-3

Östör, Andrew; Van den Bosch, Filip; Papp, Kim; Keiserman, Mauro; Blanco, Ricardo; Crowley, Angela; White, Douglas; Biljan, Ana; Madihlaba, Tshepiso; Carter, Kyle; Liu, Fang; Soliman, Ahmed M; Ashley, Doug; Chen, Michael; Glotfelty, Lila; Kivitz, Alan

EBSn, a robust synthetic reporter for monitoring ethylene responses in plants

EBSn是一种稳健的合成报告分子，可用于监测植物中的乙烯反应。

期刊:

影响因子:

doi:10.1101/2025.05.23.655144

发表日期：2025

文献求助收藏

Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial

Risankizumab治疗活动性银屑病关节炎的疗效和安全性：KEEPsAKE 1 3期随机临床试验的100周结果

期刊:Rheumatology and Therapy

影响因子:2.9

doi:10.1007/s40744-024-00654-5

Kristensen, Lars Erik; Keiserman, Mauro; Papp, Kim; McCasland, Leslie; White, Douglas; Carter, Kyle; Lippe, Ralph; Photowala, Huzefa; Drogaris, Leonidas; Soliman, Ahmed M; Chen, Michael; Padilla, Byron; Behrens, Frank

Systematic Review and Meta Analysis of the Relative Effect on Plaque Index among Pediatric Patients Using Powered (Electric) versus Manual Toothbrushes

系统评价和荟萃分析：电动牙刷与手动牙刷对儿童牙菌斑指数的相对影响

期刊:Dentistry Journal

影响因子:3.1

doi:10.3390/dj11020046

Graves, Andrew; Grahl, Troy; Keiserman, Mark; Kingsley, Karl

发表日期：2023

文献求助收藏

Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial

利沙珠单抗治疗活动性银屑病关节炎的疗效和安全性：来自随机、双盲、3期KEEPsAKE 1试验的24周结果

期刊:Annals of the Rheumatic Diseases

影响因子:20.6

doi:10.1136/annrheumdis-2021-221019

Kristensen, Lars Erik; Keiserman, Mauro; Papp, Kim; McCasland, Leslie; White, Douglas; Lu, Wenjing; Wang, Zailong; Soliman, Ahmed M; Eldred, Ann; Barcomb, Lisa; Behrens, Frank

CLASS-II KNOX genes coordinate spatial and temporal ripening in tomato

II类KNOX基因协调番茄的时空成熟过程。

期刊:Plant Physiology

影响因子:6.9

doi:10.1093/plphys/kiac290

Keren-Keiserman, Alexandra; Shtern, Amit; Levy, Matan; Chalupowicz, Daniel; Furumizu, Chihiro; Alvarez, John Paul; Amsalem, Ziva; Arazi, Tzahi; Alkalai-Tuvia, Sharon; Efroni, Idan; Ori, Naomi; Bowman, John L; Fallik, Elazar; Goldshmidt, Alexander

发表日期：2022

文献求助收藏

Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2

乌帕替尼治疗对生物制剂无效的银屑病关节炎：SELECT-PsA 2

期刊:Annals of the Rheumatic Diseases

影响因子:20.6

doi:10.1136/annrheumdis-2020-218870

Mease, Philip J; Lertratanakul, Apinya; Anderson, Jaclyn K; Papp, Kim; Van den Bosch, Filip; Tsuji, Shigeyoshi; Dokoupilova, Eva; Keiserman, Mauro; Wang, Xin; Zhong, Sheng; McCaskill, Reva M; Zueger, Patrick; Pangan, Aileen L; Tillett, William

Metabolic changes in pomegranate fruit skin following cold storage promote chilling injury of the peel

石榴果皮冷藏后代谢变化促进果皮冷害

期刊:Scientific Reports

影响因子:3.8

doi:10.1038/s41598-021-88457-4

Ravi Singh Baghel, Alexandra Keren-Keiserman, Idit Ginzberg

代谢

发表日期：2021

文献求助收藏

Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study

乌帕替尼治疗对生物制剂反应不足的银屑病关节炎患者：来自随机对照3期SELECT-PsA 2研究的56周数据

期刊:Rheumatology and Therapy

影响因子:2.9

doi:10.1007/s40744-021-00305-z

Mease, Philip J; Lertratanakul, Apinya; Papp, Kim A; van den Bosch, Filip E; Tsuji, Shigeyoshi; Dokoupilova, Eva; Keiserman, Mauro W; Bu, Xianwei; Chen, Liang; McCaskill, Reva M; Zueger, Patrick; McDearmon-Blondell, Erin L; Pangan, Aileen L; Tillett, William

EBSn, a Robust Synthetic Reporter for Monitoring Ethylene Responses in Plants

EBSn，一种用于监测植物乙烯响应的稳健合成报告分子

Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-Week Results from the KEEPsAKE 1 and KEEPsAKE 2 Randomized Clinical Trials

Risankizumab治疗活动性银屑病关节炎的疗效和安全性：KEEPsAKE 1和KEEPsAKE 2随机临床试验的196周结果

EBSn, a robust synthetic reporter for monitoring ethylene responses in plants

EBSn是一种稳健的合成报告分子，可用于监测植物中的乙烯反应。

Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial

Risankizumab治疗活动性银屑病关节炎的疗效和安全性：KEEPsAKE 1 3期随机临床试验的100周结果

Systematic Review and Meta Analysis of the Relative Effect on Plaque Index among Pediatric Patients Using Powered (Electric) versus Manual Toothbrushes

系统评价和荟萃分析：电动牙刷与手动牙刷对儿童牙菌斑指数的相对影响

Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial

利沙珠单抗治疗活动性银屑病关节炎的疗效和安全性：来自随机、双盲、3期KEEPsAKE 1试验的24周结果

CLASS-II KNOX genes coordinate spatial and temporal ripening in tomato

II类KNOX基因协调番茄的时空成熟过程。

Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2

乌帕替尼治疗对生物制剂无效的银屑病关节炎：SELECT-PsA 2

Metabolic changes in pomegranate fruit skin following cold storage promote chilling injury of the peel

石榴果皮冷藏后代谢变化促进果皮冷害

Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study

乌帕替尼治疗对生物制剂反应不足的银屑病关节炎患者：来自随机对照3期SELECT-PsA 2研究的56周数据